6533b7d0fe1ef96bd125af72

RESEARCH PRODUCT

Clinical evaluation and treatment of acute asthma exacerbations in children

S. Miceli SopoP. GianiorioP. Di PietroGiovanni Cosimo IndirliS. La GruttaF.m. De BenedictisF MonacoAngelo BarbatoR. LonghiRenato CutreraDeborah SnijdersMarzia DuseLuciana IndinnimeoP. MiglioranziM. Miraglia Del GiudiceStefania ZampognaD RadzikF. BertuolaSalvatore RennaM. La Rosa

subject

medicine.medical_specialtyImmunologyMEDLINESeverity of Illness Index; Acute Disease; Evidence-Based Medicine; Off-Label Use; Hospitalization; Humans; Treatment Outcome; Practice Guidelines as Topic; Asthma; Anti-Asthmatic Agents; Child; Child PreschoolOff-label useSeverity of Illness IndexSeverity of illnessHumansAnti-Asthmatic AgentImmunology and AllergyMedicineAnti-Asthmatic AgentsChildIntensive care medicineGrading (education)PharmacologyEvidence-Based MedicineAsthma exacerbationsbusiness.industryOff-Label UseEvidence-based medicineAsthmaHospitalizationQuality of evidenceacute asthma; children; emergency treatmentTreatment OutcomeSettore MED/38 - PEDIATRIA GENERALE E SPECIALISTICAChild PreschoolAcute DiseasePractice Guidelines as Topicacute asthma exacerbations in childrenbusinessacute asthma exacerbations in children.Clinical evaluationHuman

description

This update on treatment of asthma exacerbations in children is the result of an Italian Pediatric Society Task-force, made up of a panel of experts working in 2007–2008. The aim is to give clear indications on the use of the drugs most employed in children, grading the quality of evidence and the strength of recommendations. Suggestions on their limits due to unlicensed and off-label use are reported. The level of evidence and the strength of recommendations for different therapeutic approaches demonstrate that frequently the use of drugs in children is extrapolated from the experience in adults and that more studies are required to endorse the correct use of different drugs in asthmatic children.

http://www.scopus.com/inward/record.url?eid=2-s2.0-76349087372&partnerID=MN8TOARS